Exacerbation of livedoid vasculopathy after coronavirus disease 2019.
作者信息
Kawabe Ryoko, Tonomura Kyoko, Kotobuki Yorihisa, Ueda-Hayakawa Ikuko, Murota Hiroyuki, Fujimoto Manabu
出版信息
Eur J Dermatol. 2022 Jan 1;32(1):129-131. doi: 10.1684/ejd.2022.4200.
Abstract
摘要
相似文献
1
Exacerbation of livedoid vasculopathy after coronavirus disease 2019.2019冠状病毒病后类脂质渐进性坏死性血管病加重
Eur J Dermatol. 2022 Jan 1;32(1):129-131. doi: 10.1684/ejd.2022.4200.
2
A novel combination ("CHAP") regimen for management of livedoid vasculopathy in 12 patients.
J Am Acad Dermatol. 2023 Mar;88(3):672-674. doi: 10.1016/j.jaad.2022.06.1188. Epub 2022 Jul 1.
3
Evaluating complement dysregulation in livedoid vasculopathy using a functional assay.使用功能测定法评估类脂质渐进性坏死症中的补体失调。
Blood Adv. 2023 Nov 14;7(21):6604-6607. doi: 10.1182/bloodadvances.2022009142.
4
Treatment of Livedoid Vasculopathy With Baricitinib.用巴瑞替尼治疗类脂质渐进性坏死性血管病。
JAMA Dermatol. 2022 May 1;158(5):587-589. doi: 10.1001/jamadermatol.2022.0241.
5
Efficacy of adalimumab in the treatment of refractory livedoid vasculopathy: Case report and literature review.阿达木单抗治疗难治性类脂质渐进性坏死性血管病的疗效：病例报告及文献综述
Dermatol Ther. 2022 Sep;35(9):e15666. doi: 10.1111/dth.15666. Epub 2022 Jul 9.
6
Excellent Long-term Clinical Response to Rivaroxaban in Livedoid Vasculopathy: A Retrospective Study.利伐沙班治疗萎缩性血管病的长期临床疗效卓越：一项回顾性研究
Actas Dermosifiliogr. 2023 Feb;114(2):183-185. doi: 10.1016/j.ad.2022.03.022. Epub 2022 Sep 14.
7
Refractory livedoid vasculopathy in a child successfully treated with baricitinib.儿童难治性类脂质渐进性坏死性血管病经巴瑞替尼治疗成功
Dermatol Ther. 2022 Aug;35(8):e15659. doi: 10.1111/dth.15659. Epub 2022 Jul 4.
8
The potential role of tumor necrosis factor-α in thrombosis in livedoid vasculopathy.肿瘤坏死因子-α在类脂质渐进性坏死症血栓形成中的潜在作用。
Arch Dermatol Res. 2024 Apr 18;316(5):124. doi: 10.1007/s00403-024-02857-w.
9
The simultaneous occurrence of livedoid vasculopathy and lymphocytic thrombophilic arteritis in six cases.六例患者中同时出现类脂质血管病和淋巴细胞血栓性动脉炎。
Australas J Dermatol. 2023 Aug;64(3):413-416. doi: 10.1111/ajd.14063. Epub 2023 Apr 27.
10
Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?狼疮患者的皮肤白细胞碎裂性血管病和复发性血栓形成：抗磷脂抗体阴性的抗磷脂综合征？
Lupus. 2010 Oct;19(11):1340-3. doi: 10.1177/0961203310373783. Epub 2010 Jul 21.
引用本文的文献
1
Livedoid vasculopathy - A diagnostic and therapeutic challenge.萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.
本文引用的文献
1
Skin manifestations of COVID-19: A worldwide review.新型冠状病毒肺炎的皮肤表现：一项全球综述。
JAAD Int. 2021 Mar;2:119-133. doi: 10.1016/j.jdin.2020.12.003. Epub 2020 Dec 16.
2
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?血管性血友病因子（vWF）：COVID-19 中内皮损伤和血栓形成风险的标志物？
Clin Med (Lond). 2020 Sep;20(5):e178-e182. doi: 10.7861/clinmed.2020-0346. Epub 2020 Jul 21.
3
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.新型冠状病毒肺炎患者的皮肤表现：一个新出现问题的初步综述
Br J Dermatol. 2020 Sep;183(3):431-442. doi: 10.1111/bjd.19264. Epub 2020 Jul 5.
4
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
5
Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms.新型冠状病毒肺炎的临床表现：以上呼吸道症状为重点的系统评价
Ear Nose Throat J. 2020 Nov;99(9):569-576. doi: 10.1177/0145561320920762. Epub 2020 Apr 13.
6
Cutaneous manifestations in COVID-19: a first perspective.新型冠状病毒肺炎的皮肤表现：初步观点
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
7
Dermoscopic features of livedoid vasculopathy.类脂质渐进性坏死性血管病的皮肤镜特征。
Medicine (Baltimore). 2017 Mar;96(11):e6284. doi: 10.1097/MD.0000000000006284.
8
Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.皮肤白细胞碎裂性血管病：应用改良 Delphi 法的深入分析。
J Am Acad Dermatol. 2013 Dec;69(6):1033-1042.e1. doi: 10.1016/j.jaad.2013.07.019. Epub 2013 Sep 9.
9
Livedoid vasculopathy as a coagulation disorder.皮肤白细胞碎裂性血管病作为一种凝血障碍。
Autoimmun Rev. 2011 Apr;10(6):353-60. doi: 10.1016/j.autrev.2010.11.008. Epub 2010 Dec 22.
10
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.SARS冠状病毒功能性受体ACE2蛋白的组织分布。理解SARS发病机制的第一步。
J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
Zotero 插件